A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MTT

Search Conditions:
Search Keyword : MTT
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MTT
Appearance Frequency: 4693 time(s)
Long forms: 497

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
methyl thiazolyl tetrazolium
(2638 times)
Pharmacology
(312 times)
RT-PCR (187 times)
LDH (143 times)
ROS (132 times)
1980 The effect of amphipaths on the flavin-linked aerobic glycerol-3-phosphate dehydrogenase from Escherichia coli.
mean transit time
(963 times)
Radiology
(276 times)
CBF (291 times)
CBV (258 times)
TTP (147 times)
1975 [Isotope-angiographic measurement of aortic flow velocity for differential diagnosis of aortic sclerosis].
microculture tetrazolium
(93 times)
Pharmacology
(17 times)
FCM (8 times)
ROS (4 times)
TEM (4 times)
1992 Antitumor activity of some ruthenium derivatives in human colon cancer cell lines in vitro.
meal tolerance test
(88 times)
Endocrinology
(33 times)
OGTT (12 times)
T2DM (10 times)
BMI (8 times)
1988 Effects of cottonseed dietary fiber on metabolic parameters in diabetic rats and non-insulin-dependent diabetic humans.
Malignant triton tumor
(47 times)
Neoplasms
(14 times)
MPNST (12 times)
NF1 (4 times)
CEUS (1 time)
1985 Malignant "Triton" tumors. Natural history and immunohistochemistry of nine new cases with literature review.
mental time travel
(26 times)
Psychology
(12 times)
EFT (2 times)
AM (1 time)
ASD (1 time)
2003 Mental time travel in animals?
molecular targeted therapy
(25 times)
Neoplasms
(10 times)
HCC (3 times)
CT (2 times)
OS (2 times)
2005 [Non-small-cell lung cancer third-line therapy with gefitinib].
mammillothalamic tract
(21 times)
Neurology
(11 times)
MD (4 times)
FA (3 times)
MB (3 times)
1984 [Effect of sectioning the mammillothalamic tract on neurons of limbic nuclei of the thalamus].
mitochondrial activity
(21 times)
Toxicology
(7 times)
ALP (2 times)
HA (2 times)
HR-ICP-MS (2 times)
1997 Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates.
10  metabolic activity
(20 times)
Toxicology
(7 times)
CASA (5 times)
CAT (4 times)
MDA (4 times)
1995 Sensitivity to cadmium-induced genotoxicity in rat testicular cells is associated with minimal expression of the metallothionein gene.
11  methabenzthiazuron
(18 times)
Gastroenterology
(5 times)
FCM (10 times)
RT-PCR (7 times)
ELISA (4 times)
1999 [Effects of human BMP2 gene transfection on NIH3T3 cells in vitro].
12  monotetrazolium
(18 times)
Neoplasms
(4 times)
ELISA (3 times)
SRB (3 times)
DC (2 times)
1958 The cytochemical localization of oxidative enzymes. II. Pyridine nucleotide-linked dehydrogenases.
13  myoblast transfer therapy
(15 times)
Transplantation
(6 times)
DMD (4 times)
NK (3 times)
TA (2 times)
1992 Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.
14  1-methyltetrazole-5-thiol
(11 times)
Pharmacology
(6 times)
MTD (3 times)
ALDH (2 times)
TPMT (2 times)
1985 Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol.
15  measured using tetrazolium salt
(10 times)
Neoplasms
(3 times)
AJ (1 time)
BZs (1 time)
Con A (1 time)
1993 Hexavalent chromium produces DNA strand breakage but not unscheduled DNA synthesis at sub-cytotoxic concentrations in hepatocytes.
16  microtiter tetrazolium
(10 times)
Pharmacology
(3 times)
MDR (3 times)
2-ME (1 time)
BBB (1 time)
1998 The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
17  Mosmann's tetrazolium toxicity
(9 times)
Endodontics
(8 times)
CEM (3 times)
ANOVA (2 times)
CH (2 times)
2014 Effect of Mineral Trioxide Aggregate, Calcium-Enriched Mixture Cement and Mineral Trioxide Aggregate with Disodium Hydrogen Phosphate on BMP-2 Production.
18  mucociliary transport time
(9 times)
Otolaryngology
(7 times)
CBF (3 times)
AACR (1 time)
CVI (1 time)
1992 Influence of levocabastine suspension on ciliary beat frequency and mucociliary clearance.
19  medical team training
(8 times)
Health Services
(4 times)
OR (3 times)
CRM (1 time)
ICU (1 time)
2005 Bridging the communication gap in the operating room with medical team training.
20  methylthiotetrazole
(8 times)
General Surgery
(2 times)
AR (1 time)
BK (1 time)
BMSCs (1 time)
1984 Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.
21  mitochondrial dehydrogenase activity
(7 times)
Neurology
(2 times)
BDNF (1 time)
DMSO (1 time)
HNE (1 time)
1998 Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine.
22  modified tertrozalium salt
(7 times)
Neoplasms
(2 times)
PDGF-B (2 times)
A/R (1 time)
APC (1 time)
1999 Antiproliferative and cytotoxic effects of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with anthracycline(s), anthraquinone and nitroxides action.
23  Manual Tactile Test
(6 times)
Rehabilitation
(5 times)
CTS (2 times)
PHUA (2 times)
SWM (2 times)
2013 Establishment of a proper manual tactile test for hands with sensory deficits.
24  maximum treadmill time
(6 times)
Physiology
(2 times)
RRP (2 times)
BP (1 time)
CI (1 time)
1981 Exercise testing and ambulatory monitoring in patients with preexcitation syndrome.
25  maximum tumor thickness
(6 times)
General Surgery
(3 times)
AC (1 time)
CATV (1 time)
CRM (1 time)
1984 Long term follow-up in cutaneous malignant melanoma: the relationship of maximal tumour thickness to disease free survival, disease recurrence and death.
26  methyl tetrazolium bromide
(6 times)
Medicine
(2 times)
qRT-PCR (2 times)
CC (1 time)
FDA (1 time)
2009 Cytotoxicity of Cold Ceramic Compared with MTA and IRM.
27  Mono-nuclear cell direct cytotoxicity assay
(6 times)
Gastroenterology
(1 time)
DCs (1 time)
Dq (1 time)
EGCG (1 time)
2007 [The effects of citalopram on proliferation and differentiation of neural precursor cells from embryonic rat hippocampus].
28  multi-target tracking
(6 times)
Biosensing Techniques
(4 times)
RFS (4 times)
CASA (1 time)
CBMeMBer (1 time)
2016 Cardinality Balanced Multi-Target Multi-Bernoulli Filter with Error Compensation.
29  measured by tetrazolium
(5 times)
Parasitology
(2 times)
Acr (1 time)
BOC (1 time)
CYC (1 time)
1988 Proteinase inhibitors protect Leishmania amazonensis amastigotes from destruction by amino acid esters.
30  mixed-meal tolerance test
(5 times)
Endocrinology
(3 times)
GLP-1 (2 times)
NEFA (2 times)
T2D (2 times)
1990 Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM.
31  mucus transport time
(5 times)
Otolaryngology
(2 times)
CBF (5 times)
CPAP (1 time)
CS (1 time)
1985 Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers.
32  multiple trace theory
(5 times)
Neurology
(2 times)
MTL (2 times)
AMI (1 time)
CTT (1 time)
2003 Autobiographical memory and autonoetic consciousness: triple dissociation in neurodegenerative diseases.
33  made by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
(4 times)
Complementary Therapies
(2 times)
ET (2 times)
HAT (2 times)
MSCs (2 times)
2000 Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024.
34  mean transit time of blood
(4 times)
Neurology
(2 times)
CBF (3 times)
CBV (3 times)
MABP (3 times)
1993 Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat.
35  mean vascular transit time
(4 times)
Nuclear Medicine
(2 times)
99mTc-RBCs (1 time)
BF (1 time)
BV (1 time)
1992 O2 delivery at VO2max and oxidative capacity in muscles of standardbred horses.
36  metabolic activity assay
(4 times)
Parasites
(1 time)
ICP-MS (1 time)
mf (1 time)
SEM (1 time)
2011 Nickel induced structural and functional alterations in mouse Leydig cells in vitro.
37  method of transcriptional and translational
(4 times)
Chemistry
(1 time)
AFM (1 time)
BMSCs (1 time)
BPs (1 time)
2010 Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells.
38  methyltetrazolium assay
(4 times)
Chemistry
(2 times)
ATRP (1 time)
CFSE (1 time)
DLS (1 time)
2009 Post-hypoxic hypothermia is protective in human NT2-N neurons regardless of oxygen concentration during reoxygenation.
39  mitochondrial function
(4 times)
Complementary Therapies
(1 time)
ROS (2 times)
CAT (1 time)
CHL (1 time)
2002 Risk assessment of high-energy chemicals by in vitro toxicity screening and quantitative structure-activity relationships.
40  mouse tumor tissue
(4 times)
Endocrinology
(3 times)
MPC (4 times)
PCCs (2 times)
SDHB (2 times)
2012 Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?
41  3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide, Thiazolyl Blue Tetrazolium Bromide
(3 times)
Biochemistry
(3 times)
BMSCs (1 time)
CCK-8 (1 time)
ccRCC (1 time)
2018 Platelet-derived growth factor subunit B is required for tendon-bone healing using bone marrow-derived mesenchymal stem cells after rotator cuff repair in rats.
42  3-methyl-1-tolyltriazene
(3 times)
Chemistry Techniques, Analytical
(1 time)
CH (1 time)
DCE (1 time)
MS/MS (1 time)
1979 Aryl-monoalkyl and cyclic triazenes: direct-acting mutagens.
43  malignant teratoma trophoblastic
(3 times)
Medicine
(1 time)
MTI (2 times)
MTU (2 times)
GCT (1 time)
1986 [Experiences in the treatment of advanced nonseminomatous testicular tumor].
44  malignant tumors of trophoblast
(3 times)
Gynecology
(2 times)
CH (4 times)
CH-NST (2 times)
ETT (2 times)
2003 [Undifferentiated choriocarcinoma--epithelioid trophoblastic tumors treated at the Center for Trophoblastic Diseases in the Czech Republic 1955-2003].
45  mean tracer transit time
(3 times)
Pharmacology
(1 time)
--- 1997 Analysis of tracer transit in rat brain after carotid artery and femoral vein administrations using linear system theory.
46  Medical training therapy
(3 times)
Rehabilitation
(1 time)
--- 2001 [Medical exercise therapy--indications, tips on individualized prescription].
47  metallothionein
(3 times)
Pathology
(1 time)
Cd (1 time)
HSCs (1 time)
HSP70 (1 time)
2005 Effects of cadmium exposure on testis apoptosis in the marine teleost Gobius niger.
48  Metaphor Triads Task
(3 times)
School Health Services
(1 time)
HI (1 time)
1980 Understanding visual metaphor: developmental and individual differences.
49  Methadone Transition Treatment
(3 times)
Substance-Related Disorders
(2 times)
--- 1994 Low (40 mg) versus high (80 mg) dose methadone in a 180-day heroin detoxification program.
50  migration and in vitro vasculogenesis activity were assayed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(3 times)
Biochemistry
(1 time)
EPCs (2 times)
EPC (1 time)
Hcy (1 time)
2004 Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood.
51  mini-tracheostomy tube
(3 times)
Pulmonary Medicine
(1 time)
PCV (3 times)
BIPAP (1 time)
DMD (1 time)
2000 Assisted pressure control ventilation via a mini-tracheostomy tube for postoperative respiratory management of lung cancer patients.
52  Mitochondrial ability to reduce tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(3 times)
Biochemistry
(2 times)
AIB (1 time)
bFGF (1 time)
DA (1 time)
1992 Quantitative colorimetric assay for basic fibroblast growth factor using bovine endothelial cells and heparin.
53  mitochondrial dehydrogenase enzymatic
(3 times)
Dentistry
(3 times)
ALP (2 times)
ARS (2 times)
BMP-2 (1 time)
2017 Human dental pulp cells response to mineral trioxide aggregate (MTA) and MTA Plus: cytotoxicity and gene expression analysis.
54  mitochondrial tetrazolium
(3 times)
Biocompatible Materials
(1 time)
ALP (1 time)
Ca (1 time)
HPLC (1 time)
2003 The role of oxidant-mediated pathways in the cytotoxicity of endothelial cells exposed to mesenteric lymph from rats subjected to trauma-hemorrhagic shock.
55  mitochondrial viability
(3 times)
Metabolic Diseases
(1 time)
BA (1 time)
MDA (1 time)
MMP (1 time)
2017 Response to cooling of pony stallion semen selected by glass wool filtration.
56  mitochondrial-respiration-dependent 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
(3 times)
Allergy and Immunology
(1 time)
iNOS (2 times)
JNK (2 times)
CNTF (1 time)
2010 Supercritical fluid extraction of oregano (Origanum vulgare) essentials oils: anti-inflammatory properties based on cytokine response on THP-1 macrophages.
57  mitotane
(3 times)
Endocrinology
(3 times)
ACC (2 times)
2012 Xenograft models for preclinical drug testing: implications for adrenocortical cancer.
58  mouse tumor tissue-derived
(3 times)
Endocrinology
(2 times)
13cRA (1 time)
GHRH (1 time)
LHRH (1 time)
2013 Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
59  Multiple-Target Tracing
(3 times)
Clinical Laboratory Techniques
(2 times)
SPT (2 times)
EGFR (1 time)
2008 Dynamic multiple-target tracing to probe spatiotemporal cartography of cell membranes.
60  3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride
(2 times)
Neurology
(1 time)
BrdU (2 times)
AMD (1 time)
DHPG (1 time)
2016 Activation of type 5 metabotropic glutamate receptor promotes the proliferation of rat retinal progenitor cell via activation of the PI-3-K and MAPK signaling pathways.
61  3-methylthiazolidine-2-thione
(2 times)
Chemistry Techniques, Analytical
(2 times)
--- 2016 [Preparation of Rubber Accelerator 3-Methylthiazolidine-2-Thione and Its Spectral Analysis].
62  macrophages to reduce Alamar Blue, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(2 times)
Medicine
(1 time)
ECS (1 time)
1996 Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.
63  magnetic torque tweezers
(2 times)
Biomedical Engineering
(1 time)
FOMT (1 time)
MTs (1 time)
2011 A method to track rotational motion for use in single-molecule biophysics.
64  maintenance-tailored therapy
(2 times)
Public Health
(1 time)
SBT (1 time)
2009 A comparison of maintenance-tailored therapy (MTT) and standard behavior therapy (SBT) for the treatment of obesity.
65  malignant peripheral nerve sheath tumors, rhabdomyoblastic differentiation
(2 times)
Neoplasms
(2 times)
NF1 (2 times)
MPNSTs (1 time)
MTTs (1 time)
2013 Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
66  mammillotegmental tract
(2 times)
Radiology
(1 time)
DTT (1 time)
MLF (1 time)
2000 Myf5 is a novel early axonal marker in the mouse brain and is subjected to post-transcriptional regulation in neurons.
67  mean pulmonary transit time
(2 times)
Vascular Diseases
(1 time)
CPV (1 time)
DD (1 time)
RFR (1 time)
1981 Noninvasive measurement of cardiopulmonary blood volume. Evaluation of the centroid method.
68  Mean time transit
(2 times)
Medicine
(1 time)
CBF (2 times)
CBV (1 time)
CTA (1 time)
2006 [The contribution of perfusion CT in stroke].
69  mean transit
(2 times)
Psychiatry
(1 time)
CBF (1 time)
CBV (1 time)
1997 Processing of IgA aggregates in a rat model of chronic liver disease.
70  means of the tetrazolium derivative reduction
(2 times)
Neoplasms
(2 times)
Con A (1 time)
FCS (1 time)
PHA-L (1 time)
1997 In vitro characterization of lectin-induced alterations on the proliferative activity of three human melanoma cell lines.
71  measured by a tetrazolium based colorimetric assay
(2 times)
Neoplasms
(1 time)
BLM (1 time)
ECT (1 time)
1998 Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy.
72  measured by the tetrazolium reduction
(2 times)
Tissue Engineering
(1 time)
bFGF (1 time)
EGF (1 time)
MC540 (1 time)
2002 Photodynamic action of merocyanine 540 on carcinoma of cervix cells.
73  measured by thethiazolyl blue
(2 times)
Dentistry
(1 time)
--- 1995 Development and characterization of an in vitro gingival epithelial model.
74  measured on stellate cells and hepatocytes using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(2 times)
Pharmacology
(2 times)
--- 2002 Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
75  measuring cell survival with the tetrazolium salt reduction
(2 times)
Biomedical Engineering
(1 time)
NHPL (1 time)
OPG (1 time)
RANK (1 time)
1998 In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films.
76  medial tibial tunnels
(2 times)
Traumatology
(1 time)
ACL (2 times)
LTT (2 times)
DGA (1 time)
2012 The lateral tibial tunnel in revision anterior cruciate ligament surgery: a biomechanical study of a new technique.
77  metabolic status
(2 times)
Neoplasms
(2 times)
OA (2 times)
ALA (1 time)
DHA (1 time)
2005 Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification.
78  methyl tetrasolium test
(2 times)
Dentistry
(1 time)
CdS (1 time)
NPs (1 time)
NRU (1 time)
2009 Effects of current provisional restoration materials on the viability of fibroblasts.
79  methyl tetrazolium cytotoxicity
(2 times)
Genetics
(1 time)
AO (1 time)
CBMN (1 time)
HPRT (1 time)
2007 Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells.
80  Methyl thiazolyl tetrazolium colorimetric assay
(2 times)
Critical Care
(1 time)
Agm (1 time)
AST (1 time)
CLL (1 time)
2015 [Effects of agmatine on excessive inflammatory reaction and proliferation of splenic cells in mice with trauma].
81  methylene blue block staining and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(2 times)
Biomedical Engineering
(2 times)
GBMSCs (2 times)
BCP (1 time)
EDX (1 time)
2006 A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept.
82  microtiter
(2 times)
Neoplasms
(2 times)
SF2 (2 times)
L-Q model (1 time)
1988 Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors.
83  minimal cardiac transit times
(2 times)
Cardiology
(1 time)
--- 1972 [Minimal cardiac transit times (MTT) in heart diagnostics--measurements using gamma retina V and Indium 113m. 3. MTT in myocardial lesion and following digitalization].
84  mitochondrial colorimetric assay
(2 times)
Biocompatible Materials
(1 time)
ANOVA (1 time)
EISA (1 time)
hFOB (1 time)
2012 Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation.
85  mitogenic activity was evaluated by thiazoly blue
(2 times)
Medicine
(1 time)
PPP (2 times)
PRP (2 times)
SPGF (2 times)
2005 [Platelet-rich plasma made by a modified method promotes proliferation of rat osteoblast and human osteoblast in vitro].
86  mobile thrombolysis team
(2 times)
Neurology
(2 times)
DTN (2 times)
UC (2 times)
IS (1 time)
2017 Impact of an intrahospital mobile thrombolysis team on 3-month clinical outcomes in patients benefiting from intravenous thrombolysis for acute ischemic stroke.
87  model and colorimetric thiazolyl blue
(2 times)
Gastroenterology
(1 time)
ALP (1 time)
APS (1 time)
CK18 (1 time)
1999 Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid.
88  modern test theory
(2 times)
Statistics as Topic
(1 time)
IRT (2 times)
CTT (1 time)
HGLM (1 time)
2005 Some links between classical and modern test theory via the two-level hierarchical generalized linear model.
89  modified triple test
(2 times)
General Surgery
(2 times)
CBE (1 time)
FNAC (1 time)
NPV (1 time)
1996 Diagnosis of palpable breast lesions in younger women by the modified triple test is accurate and cost-effective.
90  molecular tagging thermometry
(2 times)
Biophysics
(1 time)
--- 2007 Molecular tagging thermometry for transient temperature mapping within a water droplet.
91  molecular-thermodynamic theory
(2 times)
Chemistry
(2 times)
DFCMC (1 time)
MD (1 time)
2017 Combined Molecular Dynamics Simulation-Molecular-Thermodynamic Theory Framework for Predicting Surface Tensions.
92  Montgomery T-tube
(2 times)
Respiratory Tract Diseases
(1 time)
--- 2010 Anastomotic stenotic complications after tracheal resections.
93  MTT reduction assay
(2 times)
Toxicology
(2 times)
ACAP (1 time)
DTP (1 time)
GSF (1 time)
1997 Toxicity assessment of 16 inorganic environmental pollutants by six bioassays.
94  MTT, STT, ln
(2 times)
Pulmonary Medicine
(1 time)
--- 1994 Longitudinal changes in time domain spirogram indices and their variability.
95  MTT-tetrazolio
(2 times)
Neurology
(1 time)
LDH (2 times)
BF (1 time)
CAT (1 time)
2016 Heavy metals produce toxicity, oxidative stress and apoptosis in the marine teleost fish SAF-1 cell line.
96  multimodality tissue tracking
(2 times)
Cardiology
(2 times)
CMR (1 time)
HARP (1 time)
ICC (1 time)
2015 Comparison of strain measurement from multimodality tissue tracking with strain-encoding MRI and harmonic phase MRI in pulmonary hypertension.
97  Multiple Tasks Test
(2 times)
Brain
(1 time)
BBS (1 time)
PD (1 time)
2001 The multiple tasks test. Strategies in Parkinson's disease.
98  1-(2-mercaptoethyl)-1,3,5-triazinane-2,4,6-trione
(1 time)
Chemistry Techniques, Analytical
(1 time)
--- 2015 A colorimetric probe to determine Pb(2+) using functionalized silver nanoparticles.
99  150-muM NMDA exposure using thiazolyl blue tetrazolium bromide
(1 time)
Molecular Biology
(1 time)
IGF-1 (1 time)
LDH (1 time)
2017 IGF-1-Involved Negative Feedback of NR2B NMDA Subunits Protects Cultured Hippocampal Neurons Against NMDA-Induced Excitotoxicity.
100  2,5-diphenyl-3,-(4,5-dimethyl-2-thiazolyl)tetrazolium bromide
(1 time)
Biology
(1 time)
DP (1 time)
GFM (1 time)
NRU (1 time)
2013 Biological safety studies of gemifloxacin mesylate and related substances.